{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:08:44Z","timestamp":1788570524601,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.vaccine.2013.11.026","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T06:44:11Z","timestamp":1385016251000},"page":"209-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A novel site-II directed glycoprotein estimation ELISA to aid rabies vaccine manufacture for veterinary and human use"],"prefix":"10.1016","volume":"32","author":[{"given":"Gontu","family":"Abhinay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Dessain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adabala","family":"Srikanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.L.","family":"Senthilkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pitta","family":"Vidyasagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alagangula","family":"Praveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.V.","family":"Chandrasekhar Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erri","family":"Swapna Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingala","family":"Rajendra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.11.026_bib0005","series-title":"Monograph 04\/2008:0216. Rabies vaccine for human use prepared in cell cultures","author":"European Pharmacopoeia","year":"2011"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0010","series-title":"Monograph 07\/2010:0451. Rabies vaccine (inactivated) for veterinary use","author":"European Pharmacopoeia","year":"2011"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0015","series-title":"Laboratory techniques in rabies","first-page":"279","article-title":"The NIH test for potency","author":"Seligmann","year":"1973"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biologicals.2012.07.005","article-title":"Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward","volume":"40","author":"Stokes","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0264-410X(88)90185-5","article-title":"NIH test, a problematic method for testing potency of inactivated rabies vaccine","volume":"6","author":"Barth","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0030","series-title":"WHO expert committee on rabies, 8th report. WHO technical report series 824","first-page":"1","author":"WHO","year":"1992"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/1045-1056(90)90037-Z","article-title":"In vitro rabies vaccine potency appraisal by ELISA: advantages of the immunocapture method with a neutralizing antiglycoprotein monoclonal antibody","volume":"18","author":"Perrin","year":"1990","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0166-0934(95)01999-5","article-title":"Rabies vaccine potency control: comparison of ELISA systems for antigenicity testing","volume":"58","author":"Rooijakkers","year":"1996","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biologicals.2005.07.004","article-title":"A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture","volume":"34","author":"Nagarajan","year":"2006","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/biol.1996.0012","article-title":"Use of ELISA for in vitro potency test of rabies vaccines for animal use","volume":"24","author":"Gamoh","year":"1996","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1045-1056(05)80062-4","article-title":"Report of a collaborative study to assess the determination of glycoprotein antigen content of rabies vaccines for human use","volume":"20","author":"Ferguson","year":"1992","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1045-1056(05)80051-X","article-title":"Rabies vaccine standardization: international collaborative study for the characterization of the fifth international standard for rabies vaccine","volume":"20","author":"Lyng","year":"1992","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0065","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/JVI.65.8.4198-4203.1991","article-title":"Antigenicity of rabies virus glycoprotein","author":"Benmansour","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-1157(85)80042-1","article-title":"Use of a monoclonal antibody for quantitation of rabies vaccine glycoprotein by enzyme immunoassay","volume":"13","author":"Lafon","year":"1985","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0075","first-page":"83","article-title":"Annex 2: recommendations for inactivated rabies vaccine for human use produced in cell substrates and embryonated eggs","volume":"vol. 941","author":"WHO","year":"2007"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0080","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1292\/jvms.65.685","article-title":"Establishment of a potency test by ELISA for a rabies vaccine for animal use in Japan","volume":"65","author":"Gamoh","year":"2003","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0092-1157(81)80068-6","article-title":"The antibody-binding test: a useful method for quantitative determination of inactivated rabies virus antigen","volume":"9","author":"Barth","year":"1981","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0264-410X(90)90176-M","article-title":"Purified chick-embryo-cell (PCEC) rabies vaccine: its potency performance in different test systems and in humans","volume":"8","author":"Barth","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0092-1157(84)80008-6","article-title":"A collaborative study on the use of single radial immunodiffusion for the assay of rabies virus glycoprotein","volume":"12","author":"Ferguson","year":"1984","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/JVI.73.1.225-233.1999","article-title":"Chimeric lyssavirus glycoproteins with increased immunological potential","volume":"73","author":"Jallet","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.11.026_bib0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1348-0421.1998.tb02270.x","article-title":"Antigenic and functional analyses of glycoprotein of rabies virus using monoclonal antibodies","volume":"42","author":"Luo","year":"1998","journal-title":"Microbiol Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13015430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13015430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T08:53:51Z","timestamp":1597049631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13015430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0264410X13015430"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel site-II directed glycoprotein estimation ELISA to aid rabies vaccine manufacture for veterinary and human use","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}